Expertise in
14
conditions

Dr. Daniel A. Nikcevich

Hematology
Essentia Health-Duluth Clinic 1st Street (Building A)
420 E 1st St, 
Duluth, MN 
Accepting New Patients
Offers Telehealth
Expertise in
14
conditions
Essentia Health-Duluth Clinic 1st Street (Building A)
420 E 1st St, 
Duluth, MN 

Overview

Daniel Nikcevich is a Hematologist practicing medicine in Duluth, Minnesota.

Dr. Nikcevich is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Large-Cell Immunoblastic Lymphoma, Richter Syndrome, and Chronic B-Cell Leukemia (CBCL).

He is actively involved in clinical research, co-authoring 14 peer reviewed articles and participating in 2 clinical trials. Dr. Nikcevich is currently accepting new patients.

Specialties

Hematology

Licenses

Internal Medicine in MN

Hospital Affiliations

Essentia Health St Mary's Medical Center
Essentia Health Deer River
Essentia Health Virginia
Essentia Health Duluth
St Marys Hospital Superior

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Itasca Medical Care
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Sanford Health
  • HMO
  • PPO
Security Health
  • EPO
  • HMO
  • INDEMNITY
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

Essentia Health-Duluth Clinic 1st Street (Building A)
420 E 1st St, Duluth, MN 55805

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients With Stage 0-III Colon or Rectal Cancer, Phase III - Preventing Adenomas of the Colon With Eflornithine and Sulindac (PACES)
A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients With Stage 0-III Colon or Rectal Cancer, Phase III - Preventing Adenomas of the Colon With Eflornithine and Sulindac (PACES)
Enrollment Status: Active_not_recruiting
Publish Date: April 02, 2026
Intervention Type: Drug
Study Phase: Phase 3
Phase III Randomized Trial of Clofarabine as Induction and Post-Remission Therapy vs. Standard Daunorubicin &Amp; Cytarabine Induction and Intermediate Dose Cytarabine Post-Remission Therapy, Followed by Decitabine Maintenance vs. Observation in Newly-Diagnosed Acute Myeloid Leukemia in Older Adults (Age >/= 60 Years)
Phase III Randomized Trial of Clofarabine as Induction and Post-Remission Therapy vs. Standard Daunorubicin &Amp; Cytarabine Induction and Intermediate Dose Cytarabine Post-Remission Therapy, Followed by Decitabine Maintenance vs. Observation in Newly-Diagnosed Acute Myeloid Leukemia in Older Adults (Age >/= 60 Years)
Enrollment Status: Completed
Publish Date: December 13, 2024
Intervention Type: Drug, Other, Procedure
Study Drugs: Clofarabine, Daunorubicin, Cytarabine, Decitabine
Study Phase: Phase 3
View 1 Less Clinical Trial

14 Total Publications

Improving Rural Clinical Trial Enrollment: Recommendations From the Rural Health Working Group of the Alliance Clinical Trials Network.
Improving Rural Clinical Trial Enrollment: Recommendations From the Rural Health Working Group of the Alliance Clinical Trials Network.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 27, 2024
Similar Doctors
Expertise in
33
conditions
Dr. Homam Alkaied
Hematology | Oncology
Expertise in
33
conditions
Dr. Homam Alkaied
Hematology | Oncology
Referral may be required

Office

1001 E Superior St Ste L101, 
Duluth, MN 
 (4.1 miles away)
218-249-3081
Languages Spoken:
English, Arabic
See accepted insurances
Accepting New Patients
Offers Telehealth

Homam Alkaied is a Hematologist and an Oncologist practicing medicine in Duluth, Minnesota. Dr. Alkaied is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Multiple Myeloma, Paget Disease of the Breast, and Pleuropulmonary Blastoma. Dr. Alkaied is currently accepting new patients.

Expertise in
22
conditions
Expertise in
22
conditions
Referral may be required

Essentia Health-Duluth Clinic 1st Street (Building A)

420 E 1st St, 
Duluth, MN 
 (0.1 miles away)
218-288-1914
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Bret Friday is a Hematologist practicing medicine in Duluth, Minnesota. Dr. Friday is highly rated in 22 conditions, according to our data. His clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer, Small Lymphocytic Lymphoma (SLL), Multiple Myeloma, Smoldering Multiple Myeloma, and Endoscopy. Dr. Friday is currently accepting new patients.

Expertise in
12
conditions
Dr. Roberto J. Fernandez
Hematology | Oncology
Expertise in
12
conditions
Dr. Roberto J. Fernandez
Hematology | Oncology
Referral may be required

St Luke's Nephrology Associates

1001 E Superior St, 
Duluth, MN 
 (0.5 miles away)
218-249-3081
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Roberto Fernandez is a Hematologist and an Oncologist practicing medicine in Duluth, Minnesota. Dr. Fernandez is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Chronic Myelogenous Leukemia (CML), Philadelphia-Negative Chronic Myeloid Leukemia, Neuroendocrine Tumor, and Chronic Lymphocytic Leukemia (CLL). Dr. Fernandez is currently accepting new patients.

Frequently Asked Questions about Dr. Daniel A. Nikcevich

How do I make an appointment with Dr. Daniel A. Nikcevich?

You can book an appointment with Dr. Daniel A. Nikcevich by calling their office at 218-212-8447. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Daniel A. Nikcevich a top-rated expert for Chronic Lymphocytic Leukemia (CLL)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Daniel A. Nikcevich is classified as an Distinguished expert for Chronic Lymphocytic Leukemia (CLL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Daniel A. Nikcevich specialize in?

While Dr. Daniel A. Nikcevich is a Hematology, they have specific expertise in Chronic Lymphocytic Leukemia (CLL), Large-Cell Immunoblastic Lymphoma, and Richter Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Daniel A. Nikcevich participate in research or clinical trials?

Yes. Dr. Daniel A. Nikcevich has published 14 articles and abstracts on conditions like Chronic Lymphocytic Leukemia (CLL). You can view a list of Dr. Daniel A. Nikcevich's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Daniel A. Nikcevich accept my insurance?

Dr. Daniel A. Nikcevich accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 218-212-8447 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Nikcevich's expertise for a condition
ConditionClose
    View All 11 Advanced Conditions
    View All 70 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile